GALERA THERAPEUTICS INC's ticker is GRTX and the CUSIP is 36338D108. A total of 32 filers reported holding GALERA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $497 | -97.5% | 2,834 | -55.3% | 0.00% | – |
| Q2 2023 | $19,799 | -86.5% | 6,346 | -88.9% | 0.00% | – |
| Q1 2023 | $146,266 | +25031.6% | 57,135 | +14512.5% | 0.00% | – |
| Q4 2022 | $582 | -70.9% | 391 | -63.9% | 0.00% | – |
| Q3 2022 | $2,000 | -66.7% | 1,082 | -73.7% | 0.00% | – |
| Q2 2022 | $6,000 | -53.8% | 4,107 | -26.0% | 0.00% | – |
| Q1 2022 | $13,000 | -98.5% | 5,548 | -97.1% | 0.00% | – |
| Q4 2021 | $874,000 | +1842.2% | 190,516 | +3297.2% | 0.00% | – |
| Q3 2021 | $45,000 | -21.1% | 5,608 | -5.0% | 0.00% | – |
| Q2 2021 | $57,000 | -47.2% | 5,901 | -52.1% | 0.00% | – |
| Q1 2021 | $108,000 | -34.1% | 12,307 | -23.0% | 0.00% | – |
| Q4 2020 | $164,000 | +556.0% | 15,987 | +475.7% | 0.00% | – |
| Q3 2020 | $25,000 | -39.0% | 2,777 | -52.1% | 0.00% | – |
| Q2 2020 | $41,000 | -8.9% | 5,793 | +22.0% | 0.00% | – |
| Q1 2020 | $45,000 | +45.2% | 4,747 | +101.5% | 0.00% | – |
| Q4 2019 | $31,000 | – | 2,356 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nan Fung Group Holdings Ltd | 613,223 | $913,702 | 0.63% |
| SECTORAL ASSET MANAGEMENT INC | 1,666,666 | $2,483,332 | 0.48% |
| Sofinnova Investments, Inc. | 3,083,712 | $4,594,731 | 0.27% |
| Novo Holdings A/S | 2,459,021 | $3,663,941 | 0.23% |
| Tekla Capital Management LLC | 898,374 | $1,338,577 | 0.05% |
| Blackstone Inc. | 1,678,984 | $2,501,686 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 187,000 | $278,630 | 0.01% |
| Ensign Peak Advisors, Inc | 151,777 | $226,148 | 0.00% |
| TCI Wealth Advisors, Inc. | 6,162 | $9,181 | 0.00% |
| Tower Research Capital LLC (TRC) | 17,819 | $27 | 0.00% |